34 Polen Capital Regeneron Pharmaceuticals Trades
The first Regeneron Pharmaceuticals trade was made in Q2 2013. Since then Polen Capital bought shares 23 more times and sold shares on ten occasions. The investor completely sold their stake between Q4 2021 and Q2 2022.
News about Regeneron Pharmaceuticals, Inc. and Polen Capital
Hedge Fund and Insider Trading News: Bill Ackman, Starboard Value, Citadel LLC, Rokos Capital Management, Pantera Capital, Regeneron Pharmaceuticals, Inc. (REGN), and More
Citadel Made More Than $4 Billion From Commodities In 2023 (Bloomberg) Pantera Capital Reveals $500 Billion Opportunity For Bitcoin (The Street) Jeffrey Epst...
Regeneron Pharmaceuticals (NASDAQ:REGN) PT Raised to $1,082.00
Regeneron Pharmaceuticals (NASDAQ:REGN – Get Free Report) had its target price boosted by equities research analysts at BMO Capital Markets from $1,055.00 to...
RBC ups Regeneron to outperform; cites Eylea patent win, Dupi sales
RBC Capital Markets has upgraded Regeneron Pharmaceuticals (REGN) to outperform, citing the company’s R&D pipeline, “strong” Dupi performance and “solid” Eylea
Arjuna Capital Has $1.17 Million Stock Position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)
… Stock Analysis on Regeneron Pharmaceuticals Regeneron Pharmaceuticals Trading Down 1. … stock. About Regeneron Pharmaceuticals (Free Report) Regeneron Phar...